Leven Labs, Inc. – Trademark Portfolio
Entity Type: 03
Leven Labs, Inc. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 8 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 5 trademarks are registered and 2 are pending. Notable registered marks include MAIGIC, ADMIRAL, 1-CLICK ALLOWLIST, 1-CLICK WHITELIST, and THE VISITOR RELATIONSHIP MANAGEMENT COMPANY. The owner is based in Gainesville, FL.
Suite 265
747 SW 2nd Ave.
Gainesville, FL 32601
Showing of trademarks Trademarks
Trademark Classifications
Leven Labs, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Leven Labs, Inc. have?
Leven Labs, Inc. has 9 U.S. trademarks filed with the USPTO. Of these, 5 registered, 2 pending, 2 abandoned.
What trademark classes does Leven Labs, Inc. file in?
Leven Labs, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Leven Labs, Inc.'s most well-known trademarks?
Leven Labs, Inc.'s registered trademark portfolio includes well-known marks such as MAIGIC, ADMIRAL, 1-CLICK ALLOWLIST, 1-CLICK WHITELIST, and THE VISITOR RELATIONSHIP MANAGEMENT COMPANY. These are among 5 currently registered trademarks in the portfolio.
What is Leven Labs, Inc.'s trademark registration success rate?
Leven Labs, Inc. has a 71% trademark registration rate, with 5 out of 7 resolved applications resulting in successful registration. Currently, 2 applications are pending review.